Webcast

Prescient Therapeutics Investor Briefing – 14 August

August 14, 2020

Prescient Therapeutics Investor Briefing – 14 August

Prescient Therapeutics (ASX: PTX) Webcast Replay

Steven Yatomi-Clarke, CEO & MD of Prescient Therapeutics (ASX:PTX) provides an update on the company’s next-gen CAR-T asset enhanced cell therapy capabilities – maybe the most promising global frontier in the fight against cancer – as well as their other cancer therapy programs.

Recorded on 14 August 2020 at 11 am (AEST).

Join the next Prescient Therapeutics webcast

Speak to our Advisor team about this company

FEATURE SPEAKERS

WARRICK LACE

Investor Relation Manager - Reach Markets

STEVEN YATOMI-CLARKE

Chief Executive Officer & Managing Director - Prescient Therapeutics

Speak to our Advisor team about this company



By clicking submit, I agree to the terms of the Reach Markets Financial Services Guide that includes the Privacy Statement.